Bio-Thera Solutions Ltd (688177) - Total Liabilities

Latest as of June 2025: CN¥1.66 Billion CNY ≈ $243.43 Million USD

Based on the latest financial reports, Bio-Thera Solutions Ltd (688177) has total liabilities worth CN¥1.66 Billion CNY (≈ $243.43 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Bio-Thera Solutions Ltd cash flow conversion to assess how effectively this company generates cash.

Bio-Thera Solutions Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Bio-Thera Solutions Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Bio-Thera Solutions Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Bio-Thera Solutions Ltd Competitors by Total Liabilities

The table below lists competitors of Bio-Thera Solutions Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
China Modern Dairy Holdings Ltd F:07M	Germany	€23.33 Billion
Jsti Group SHE:300284	China	CN¥6.81 Billion
Develop Global Ltd AU:DVP	Australia	AU$269.24 Million
HannStar Board Corp TW:5469	Taiwan	NT$57.47 Billion
Eit Environmental Development Group SHE:300815	China	CN¥4.97 Billion
Advtech JSE:ADH	South Africa	ZAC4.68 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Bio-Thera Solutions Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688177 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.79	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.85	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.74	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bio-Thera Solutions Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bio-Thera Solutions Ltd (2016–2024)

The table below shows the annual total liabilities of Bio-Thera Solutions Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.50 Billion ≈ $219.12 Million	+39.38%
2023-12-31	CN¥1.07 Billion ≈ $157.22 Million	+87.67%
2022-12-31	CN¥572.48 Million ≈ $83.77 Million	+7.96%
2021-12-31	CN¥530.27 Million ≈ $77.60 Million	+36.82%
2020-12-31	CN¥387.56 Million ≈ $56.71 Million	+1.01%
2019-12-31	CN¥383.68 Million ≈ $56.15 Million	+74.85%
2018-12-31	CN¥219.44 Million ≈ $32.11 Million	-19.14%
2017-12-31	CN¥271.39 Million ≈ $39.71 Million	+56.10%
2016-12-31	CN¥173.86 Million ≈ $25.44 Million	--

About Bio-Thera Solutions Ltd

SHG:688177 China Biotechnology

Market Cap

$1.25 Billion

CN¥8.53 Billion CNY

Market Cap Rank

#8157 Global

#2064 in China

Share Price

CN¥20.60

Change (1 day)

-0.43%

52-Week Range

CN¥20.50 - CN¥34.72

All Time High

CN¥71.90